help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dandekar, A. A.
Right arrow Articles by Perlman, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dandekar, A. A.
Right arrow Articles by Perlman, S.
(American Journal of Pathology. 2004;164:363-369.)
© 2004 American Society for Investigative Pathology


Short Communication

Bystander CD8 T-Cell-Mediated Demyelination is Interferon-{gamma}-Dependent in a Coronavirus Model of Multiple Sclerosis

Ajai A. Dandekar*, Daniela Anghelina{dagger} and Stanley Perlman*{dagger}{ddagger}§

From the Interdisciplinary Programs in Immunology* and Neuroscience,{dagger} and the Departments of Pediatrics{ddagger} and Microbiology,§ University of Iowa, Iowa City, Iowa

Mice infected with the coronavirus mouse hepatitis virus, strain JHM (JHM) develop a disease that shares many histological characteristics with multiple sclerosis. We previously demonstrated that JHM-infected mice that only have CD8 T cells specific for an epitope not in the virus develop demyelination on specific activation of these cells. Herein we show that this process of bystander T-cell-mediated demyelination is interferon-{gamma} (IFN-{gamma})-dependent. The absence of IFN-{gamma} abrogated demyelination but did not change T-cell infiltration or expression levels of inflammatory cytokines or chemokines in the spinal cord. These results are consistent with models in which IFN-{gamma} contributes to CD8 T-cell-mediated demyelination by activation of macrophages/microglia, the final effector cells in the disease process.





This article has been cited by other articles:


Home page
J. Immunol.Home page
K. B. Walsh, R. A. Edwards, K. M. Romero, M. V. Kotlajich, S. A. Stohlman, and T. E. Lane
Expression of CXC Chemokine Ligand 10 from the Mouse Hepatitis Virus Genome Results in Protection from Viral-Induced Neurological and Liver Disease
J. Immunol., July 15, 2007; 179(2): 1155 - 1165.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
I. Tsunoda, L.-Q. Kuang, M. Kobayashi-Warren, and R. S. Fujinami
Central Nervous System Pathology Caused by Autoreactive CD8+ T-Cell Clones following Virus Infection
J. Virol., December 1, 2005; 79(23): 14640 - 14646.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. S. Kim and S. Perlman
Viral Expression of CCL2 Is Sufficient To Induce Demyelination in RAG1-/- Mice Infected with a Neurotropic Coronavirus
J. Virol., June 1, 2005; 79(11): 7113 - 7120.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. B. McGavern and P. Truong
Rebuilding an Immune-Mediated Central Nervous System Disease: Weighing the Pathogenicity of Antigen-Specific versus Bystander T Cells
J. Immunol., October 15, 2004; 173(8): 4779 - 4790.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Society for Investigative Pathology.